Rury R. Holman - Concepedia

Author

Rury R. Holman

Oxford Centre for Diabetes, Endocrinology and Metabolism ORCID

Also Known As

Bastos, M. H., Bethel, M. Angelyn, D. R. Matthews, Davidson, Mayer B., Gerstein, Hertzel C., Holman, R, Holman, RR, Holman, Rury R., I.M. Stratton, Kaixin Zhou

579

Publications

61.2K

Citations

H-Index

129

Concepts

All Affiliations

Oxford Centre for Diabetes, Endocrinology and Metabolism University of Oxford Clinical Research Institute Duke University University of Toronto

About

Rury R. Holman is an author at Oxford Centre for Diabetes, Endocrinology and Metabolism specializing in medicine, diabetes, and metabolic syndrome.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	46	84	19.2K
2	Health Sciences	16	18	2.4K
3	Education	1	1	297
4	Engineering	1	1	22
5	Nursing	1	1	42

Rury R. Holman

244

Publications

53K

Citations

H-Index

Page 1

	Year	Citations
10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes Rury R. Holman, Sanjoy K. Paul, M. Angelyn Bethel, New England Journal of Medicine	2008	7.6K
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy David M. Nathan, John B. Buse, Mayer B. Davidson, Diabetes Care Metabolic SyndromeDiabetes ManagementHealth PolicyInsulin ManagementDiabetes	2008	3.8K
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy Steven E. Kahn, Steven M. Haffner, Mark Heise, New England Journal of Medicine	2006	2.9K
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes Jennifer B. Green, M. Angelyn Bethel, Paul W. Armstrong, New England Journal of Medicine	2015	2.5K
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes Rury R. Holman, M. Angelyn Bethel, Robert J. Mentz, New England Journal of Medicine	2017	2.1K
Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23) R. C. Turner, Helen Millns, H. A. W. Neil, BMJ	1998	2K
Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64) Amanda Adler, Richard Stevens, Susan E. Manley, Kidney International GlomerulonephritisUrologyRenal DiseaseDiabetes EpidemiologyMedicine	2003	1.8K
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, The Lancet Diabetes ManagementCardiovascular DiseaseDiabetesClinical TrialsType 2	2018	1.7K
Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy David M. Nathan, John B. Buse, Mayer B. Davidson, Diabetes Care HypertensionObesityMetabolic SyndromeDiabetes EpidemiologyInsulin Delivery	2006	1.2K
UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis Irene Stratton, Eva M. Kohner, S J Aldington, Diabetologia Diabetic RetinopathyOcular DiseaseDiabetes EpidemiologyOphthalmologyDiabetes	2001	1K

Page 1